Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by rbm0524on Jun 27, 2018 2:02pm

168 Views

Post# 28238437

RE:RE:RE:RE:RE:Sernova's $2 Million PP - replaces expiring warrants :(

Really nopoo? Just extend the warrants? SVA only gets money in the door if people exercise their warrants and they aren't doing so if they aren't in the money. The previous warrants expire and go away, thus the fully diluted float doesn't change a ton.

nopoo wrote: If they thought the share price was going above .35 why not just extend the warrants @ .35 expiring the end of June instead of a new PP and new dilution? Especially after our IR was telling investors no PP 'We're chasing pharma bucks."

ttfn
nopoo

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue